Lucas C - Search Results

1

Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer.

Rougier P, Chabot GG, Bonneterre J, Tigaud JM, Lucas C, Baud M, Bérille J, Gouyette A. Rougier P, et al. Among authors: lucas c. Eur J Cancer. 1993;29A(2):288-9. doi: 10.1016/0959-8049(93)90200-y. Eur J Cancer. 1993. PMID: 8422301 Clinical Trial. No abstract available.

2

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.

Le Cesne A, Chabot G, Bérille J, Lucas C, Baud M, Gouyette A, Marty M, Le Chevalier T. Le Cesne A, et al. Among authors: lucas c. Lung Cancer. 1995 Aug;13(1):69-78. doi: 10.1016/0169-5002(95)00479-k. Lung Cancer. 1995. PMID: 8528641 Clinical Trial.

3

Phase I pharmacological study of intra-arterially infused fotemustine for colorectal liver metastases.

Hartmann JT, Schmoll E, Bokemeyer C, Fety R, Lucas C, Giroux B, Schmoll HJ. Hartmann JT, et al. Among authors: lucas c. Eur J Cancer. 1998 Jan;34(1):87-91. doi: 10.1016/s0959-8049(97)00359-6. Eur J Cancer. 1998. PMID: 9624243 Clinical Trial.

4

Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.

Gerard B, Aamdal S, Lee SM, Leyvraz S, Lucas C, D'Incalci M, Bizzari JP. Gerard B, et al. Among authors: lucas c. Eur J Cancer. 1993;29A(5):711-9. doi: 10.1016/s0959-8049(05)80352-1. Eur J Cancer. 1993. PMID: 8471329

5

Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: a French cancer centre multicentric study.

Iliadis A, Launay-Iliadis MC, Lucas C, Fety R, Lokiec F, Tranchand B, Milano G. Iliadis A, et al. Among authors: lucas c. Eur J Cancer. 1996 Mar;32A(3):455-60. doi: 10.1016/0959-8049(95)00565-x. Eur J Cancer. 1996. PMID: 8814692

6

Methods for the analysis of the new vinca alkaloid derivative, S 12363, in plasma by high-performance liquid chromatography with fluorescence detection.

Gordon BH, Bakes DM, Bennett P, LeBras B, Walther B, Lucas C, Marc S, Gouyette A. Gordon BH, et al. Among authors: lucas c. J Chromatogr B Biomed Appl. 1994 Jul 1;657(1):163-71. doi: 10.1016/0378-4347(94)80083-9. J Chromatogr B Biomed Appl. 1994. PMID: 7952064

7

[Study of the clinical pharmacokinetics of fotemustine in various tumor indications].

Lokiec F, Beerblock K, Deloffre P, Lucas C, Bizzari JP. Lokiec F, et al. Among authors: lucas c. Bull Cancer. 1989;76(10):1063-9. Bull Cancer. 1989. PMID: 2635634 French.

8

Hepatic intra-arterial infusion of fotemustine: pharmacokinetics.

Fety R, Lucas C, Solere P, Cour V, Vignoud J. Fety R, et al. Among authors: lucas c. Cancer Chemother Pharmacol. 1992;31(2):118-22. doi: 10.1007/BF00685097. Cancer Chemother Pharmacol. 1992. PMID: 1451232

9

[Interspecies comparison of pharmacokinetic parameters of fotemustine (nitrosourea S 10036): mice, rats, monkeys, dogs and man].

Lucas C, Ings B, Gray AJ, Deloffre P, Lokiec F, Campbell B, Beerblock K. Lucas C, et al. Bull Cancer. 1989;76(8):863-5. Bull Cancer. 1989. PMID: 2515897 French. No abstract available.

10

Phase I pharmacokinetics study of high-dose fotemustine and its metabolite 2-chloroethanol in patients with high-grade gliomas.

Tranchand B, Lucas C, Biron P, Giroux B, Gordon B, Richards R, Solere P, Roux N, Evene E, Mornex F, et al. Tranchand B, et al. Among authors: lucas c. Cancer Chemother Pharmacol. 1993;32(1):46-52. doi: 10.1007/BF00685875. Cancer Chemother Pharmacol. 1993. PMID: 8462123 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,225 results

Search Page

Filters